- Filed
- May 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 10.98M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $935.92K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.14M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.42M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.48M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.32M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.61M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.32M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.61M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 101.45K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.62M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $7.52M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $7.28M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$28.13 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$28.13 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.64M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $2.54M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.85M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$5.18M |